Indeed, inactivation of RIPK1 activity either by Nec-1S or genetic modification greatly protected ConA-challenged mice from hepatitis, demonstrating a key role of RIPK1 kinase activity in ConA-induced hepatocyte death. This evidence concerns the gene RIPK1 and hepatitis A virus infection.